Captrust Financial Advisors Takeda Pharmaceutical CO LTD Transaction History
Captrust Financial Advisors
- $34.2 Billion
- Q4 2024
A detailed history of Captrust Financial Advisors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Captrust Financial Advisors holds 17,434 shares of TAK stock, worth $236,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,434
Previous 24,136
27.77%
Holding current value
$236,056
Previous $342,000
32.75%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding TAK
# of Institutions
335Shares Held
69.1MCall Options Held
1.99MPut Options Held
171K-
Capital Research Global Investors Los Angeles, CA13.2MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$75.8 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$62.7 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$57.1 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$43.9 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...